Clinical Trial

A Phase II Study of Sunitinib or Temsirolimus in Patients With Advanced Rare Tumours

Name: A Phase II Study of Sunitinib or Temsirolimus in Patients With Advanced Rare Tumours — clinical trial record (NCT01396408)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Active, Not Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

This research is being done because there is no treatment that will cure this type of cancer. Although some types of chemotherapy can cause this cancer to shrink for a time, better options are needed.

Protocol Amendment History 1 change

minor Completion pushed: 2026-06-30 -> 2026-12-31 2026-08-12

Trial Details

NCT Number	NCT01396408
Lead Sponsor	Canadian Cancer Trials Group Collaborators: Pfizer
Conditions	Advanced Rare Tumours
Enrollment	137 participants
Start Date	2012-02-09
Primary Completion	2015-07-06 (estimated)
Study Completion	2026-12-31 (estimated)
Updated on ClinicalTrials.gov	2026-08-11